Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

被引：135

作者：

Zhou, Jian

Sun, Huichuan

Wang, Zheng

Cong, Wenming

Zeng, Mengsu

Zhou, Weiping

Bie, Ping

Liu, Lianxin

Wen, Tianfu

Kuang, Ming

Han, Guohong

Yan, ZhiPing

Wang, Maoqiang

Liu, Ruibao

Lu, Ligong

Ren, Zhenggang

Zeng, ZhaoChong

Liang, Ping

Liang, Changhong

Chen, Min

Yan, Fuhua

Wang, Wenping

Hou, Jinlin

Ji, Yuan

Yun, Jingping

Bai, Xueli

Cai, Dingfang

Chen, Weixia

Chen, Yongjun

Cheng, Wenwu

Cheng, Shuqun

Dai, Chaoliu

Guo, Wenzhi

Guo, Yabing

Hua, Baojin

Huang, Xiaowu

Jia, Weidong

Li, Qiu

Li, Tao

Li, Xun

Li, Yaming

Li, Yexiong

Liang, Jun

Ling, Changquan

Liu, Tianshu

Liu, Xiufeng

Lu, Shichun

Lv, Guoyue

Mao, Yilei

Meng, Zhiqiang

机构：

[1] Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai

[2] Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai

[3] Department of Pathology, The Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai

[4] Department of Hepatobiliary and Spleenary Surgery, The Affiliated Shengjing Hospital, China Medical University, Shenyang

[5] Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai

[6] Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou

[7] The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai

[8] Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou

[9] Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing

[10] Graduate School, Beijing University of Chinese Medicine, Beijing

[11] Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin

[12] Department of Hepatic Surgery, Affiliated Provincial Hospital, Anhui Medical University, Hefei

[13] Department of Liver Surgery, West China Hospital of Sichuan University, Chengdu

[14] Department of Oncology, West China Hospital, Sichuan University, Chengdu

[15] Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou

[16] Department of General Surgery, Qilu Hospital, Shandong University, Jinan

[17] Department of Liver Diseases and Digestive Interventional Radiology, Xijing Hospital, Fourth Military Medical University, Xi'an

[18] The First Hospital of Lanzhou University, Lanzhou

[19] Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai

[20] Department of Nuclear Medicine, The First Hospital of China Medical University, Shenyang

[21] Department of Interventional Radiology, Chinese PLA General Hospital, Beijing

[22] Department of Radiation Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

[23] Department of Interventional Radiology, The Tumor Hospital of Harbin Medical University, Harbin

[24] Department of Oncology, Peking University International Hospital, Beijing

[25] Department of Interventional Oncology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou

[26] Changhai Hospital of Traditional Chinese Medicine, Second Military Medical University, Shanghai

[27] Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai

[28] Department of Oncology, Zhongshan Hospital, Fudan University, Shanghai

[29] Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing

[30] Department of Medical Oncology, PLA Cancer Center, Nanjing Bayi Hospital, Nanjing

[31] Department of Radiology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou

[32] Institute and Hospital of Hepatobiliary Surgery of Chinese PLA, Chinese PLA Medical School, Chinese PLA General Hospital, Beijing

[33] Editorial Department of Chinese Journal of Digestive Surgery, Chongqing

[34] Department of General Surgery, The First Hospital of Jilin University, Jilin

[35] Department of Radiology, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai

[36] Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Beijing

[37] Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai

[38] Department of Oncology, Shanghai Medical College, Fudan University, Shanghai

[39] Department of Infectious Diseases, State Key Laboratory of Organ Failure Research, Nanfang Hospital Southern Medical University, Guangzhou

[40] Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning

[41] Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai

[42] Department of Interventional Radiology the First Affiliated Hospital of Xinjiang Medical University, Urumqi

[43] Department of Pathology, Tumor Prevention and Treatment Center, Sun Yat-sen University, Guangzhou

[44] Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai

[45] Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine Zhejiang University, Hangzhou

[46] Department of Hepatobiliary Surgery, Tianjin Medical University Cancer Institute and Hospital, Tianjin

[47] Department of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai

[48] Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an

[49] Department of Radiology, West China Hospital of Sichuan University, Chengdu

[50] Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai

来源：

LIVER CANCER | 2023年 / 12卷 / 05期

关键词：

Primary liver cancer; hepatocellular carcinoma; guidelines; China; diagnosis; treatment; UNRESECTABLE HEPATOCELLULAR-CARCINOMA; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; CONTRAST-ENHANCED ULTRASOUND; RANDOMIZED CONTROLLED-TRIAL; STEREOTACTIC BODY RADIOTHERAPY; PREOPERATIVE TRANSARTERIAL CHEMOEMBOLIZATION; SIROLIMUS-BASED IMMUNOSUPPRESSION; VS. RADIOFREQUENCY ABLATION; SURGICAL RESECTION; OPEN-LABEL;

D O I：

10.1159/000530495

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Primary liver cancer, around 75%-85% are hepatocellular carcinoma in China, is the fourth most common malignancy and the second leading cause of tumor-related death, thereby posing a significant threat to the life and health of the Chinese people.Summary: Since the publication of Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China in June 2017, which were updated by the National Health Commission in December 2019, additional high-quality evidence has emerged from researchers worldwide regarding the diagnosis, staging, and treatment of liver cancer, that requires the guidelines to be updated again. The new edition (2022 Edition) was written by more than 100 experts in the field of liver cancer in China, which not only reflects the real-world situation in China, but also may re-shape the nationwide diagnosis and treatment of liver cancer. Key Messages: The new guideline aims to encourage the implementation of evidence-based practice, and improve the national average five-year survival rate for patients with liver cancer, as proposed in the "Health China 2030 Blueprint."

引用

页码：405 / 444

页数：40

共 50 条

[21] The Japanese Breast Cancer Society Clinical Practice Guidelines for surgical treatment of breast cancer, 2022 edition
Takehiko Sakai
Goro Kutomi
Tadahiko Shien
Sota Asaga
Tomoyuki Aruga
Makoto Ishitobi
Sayaka Kuba
Masataka Sawaki
Kaori Terata
Koichi Tomita
Chikako Yamauchi
Yutaka Yamamoto
Hiroji Iwata
Shigehira Saji
Breast Cancer, 2024, 31 : 1 - 7
[22] The Japanese breast cancer society clinical practice guidelines for radiation treatment of breast cancer, 2022 edition
Yoshimura, Michio
Yamauchi, Chikako
Sanuki, Naoko
Hamamoto, Yasushi
Hirata, Kimiko
Kawamori, Jiro
Kawamura, Mariko
Ogita, Mami
Yamamoto, Yutaka
Iwata, Hiroji
Saji, Shigehira
BREAST CANCER, 2024, 31 (03) : 347 - 357
[23] National guidelines for diagnosis and treatment of lung cancer 2022 in China(English version)
Nan Wu
Jia Wang
Quanne Wang
ChineseJournalofCancerResearch, 2022, 34 (03) : 176 - 206
[24] National guidelines for diagnosis and treatment of prostate cancer 2022 in China(English version)
Yong Yang
ChineseJournalofCancerResearch, 2022, 34 (03) : 270 - 288
[25] National guidelines for diagnosis and treatment of gastric cancer 2022 in China(English version)
Jiafu Ji
Zhaode Bu
Jiahui Chen
Chinese Journal of Cancer Research, 2022, 34 (03) : 207 - 242
[26] National guidelines for diagnosis and treatment of breast cancer 2022 in China(English version)
Xinguang Wang
Xue Chen
Dongfeng Niu
Yang Yang
Jingyi Zhao
ChineseJournalofCancerResearch, 2022, 34 (03) : 151 - 175
[27] National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China(English version)
Baocai Xing
Kemin Jin
ChineseJournalofCancerResearch, 2022, 34 (03) : 238 - 264
[28] National guidelines for diagnosis and treatment of thyroid cancer 2022 in China(English version)
Shaoyan Liu
Yansong Lin
Yiming Zhu
Lin Gui
Xiaorong Hou
Ziren Kong
Yuanlin Piao
Yuqing Sun
Hao Wang
Jian Wang
Bo Zhang
Ye Zhang
Kun Zheng
Chinese Journal of Cancer Research, 2022, 34 (03) : 131 - 150
[29] National guidelines for diagnosis and treatment of cervical cancer 2022 in China(English version)
Naiyi Zhang
Yidi Yuan
Chinese Journal of Cancer Research, 2022, 34 (03) : 256 - 269
[30] Guidelines for diagnosis and treatment of primary aldosteronism
Januszewicz, Andrzej
Kokot, Franciszek
Widecka, Krystyna
Wiecek, Andrzej
Czekalski, Stanislaw
Cieszanowski, Andrzej
Ciechanowicz, Andrzej
Chudek, Jerzy
Dobrucki, Tomasz
Florczak, Elibieta
Gaciong, Zbigniew
Gluszek, Jerzy
Grodzicki, Tomasz
Janaszek-Sitkowska, Hanna
Januszewicz, Magdalena
Januszewicz, Wlodzimierz
Kabat, Marek
Kasperlik-Zaluska, Anna
Krolicki, Leszek
Litwin, Mieczyslaw
Makowiecka-Ciesla, Magdalena
Narkiewicz, Krzysztof
Otto, Maciej
Prejbisz, Aleksander
Romer, Tomasz
Sznajderman, Marek
Tykarski, Andrzej
Walecki, Jerzy M.
Wasiutynski, Aleksander
Zgliczynski, Wojciech
ARTERIAL HYPERTENSION, 2008, 12 (03): : 155 - 168

← 1 2 3 4 5 →